RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for children with returning leukemia: blinatumomab trial launches in china
Disease control OngoingThis study tests a drug called blinatumomab in Chinese children (ages 1 month to 18 years) whose B-cell acute lymphoblastic leukemia has come back or not responded to standard treatment. The main goal is to see how many children achieve complete remission. The study also monitors…
Matched conditions: RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated May 17, 2026 13:56 UTC
-
New CAR T-Cell therapy shows promise for tough blood cancers
Disease control OngoingThis study tests a treatment called KTE-X19, a type of cell therapy that uses a patient's own immune cells to fight cancer. It is for Japanese adults with two types of blood cancer that have come back or not responded to other treatments: mantle cell lymphoma and B-cell acute lym…
Matched conditions: RELAPSED/REFRACTORY B PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC